Our findings showed that depressed patients had marginally greater levels of inflammatory conditions than those without depression, and multifarious cytokines were activated, containing IL-1, IL-6, TNF-α, and CRP, which was harmonious with the conclusions of accessible inflammation research in other cancer types (17, 25, 26). This evidence concerns the gene IL6 and depressive symptom measurement.